+13.1%
GSK vs TENB
+64.9%
-51.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +0.7% | +4.4% | +5.1% |
| 7D | +4.9% | -2.8% | +7.8% | +4.8% |
| 30D | +9.9% | +22.9% | -13.0% | +11.0% |
| 3M | +0.2% | +31.7% | -31.6% | +1.2% |
| 6M | +2.3% | +127.3% | -124.9% | +7.8% |
| YTD | +7.1% | +101.2% | -94.1% | +14.3% |
| 1Y | +13.1% | +68.7% | -55.6% | +24.7% |
| All | +13.1% | +64.9% | -51.8% | +24.7% |
Cumulative growth
Daily Returns
Daily percentage return beside TENB.
Daily Out/Under-Performance
Portfolio return minus TENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling